These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

743 related items for PubMed ID: 19697403

  • 1. Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso.
    Tebit DM, Sangaré L, Tiba F, Saydou Y, Makamtse A, Somlare H, Bado G, Kouldiaty BG, Zabsonre I, Yameogo SL, Sathiandee K, Drabo JY, Kräusslich HG.
    J Med Virol; 2009 Oct; 81(10):1691-701. PubMed ID: 19697403
    [Abstract] [Full Text] [Related]

  • 2. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
    Nadembega WM, Giannella S, Simpore J, Ceccherini-Silberstein F, Pietra V, Bertoli A, Pignatelli S, Bellocchi MC, Nikiema JB, Cappelli G, Bere A, Colizzi V, Perno CP, Musumeci S.
    J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
    [Abstract] [Full Text] [Related]

  • 3. Absence of genotypic drug resistance and presence of several naturally occurring polymorphisms of human immunodeficiency virus-1 CRF06_cpx in treatment-naive patients in Estonia.
    Avi R, Huik K, Sadam M, Karki T, Krispin T, Ainsalu K, Paap P, Schmidt J, Nikitina N, Lutsar I.
    J Med Virol; 2009 Jun; 81(6):953-8. PubMed ID: 19382254
    [Abstract] [Full Text] [Related]

  • 4. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [Abstract] [Full Text] [Related]

  • 5. Molecular diversity and polymerase gene genotypes of HIV-1 among treatment-naïve Cameroonian subjects with advanced disease.
    Soares EA, Makamche MF, Siqueira JD, Lumngwena E, Mbuagbaw J, Kaptue L, Asonganyi T, Seuánez HN, Soares MA, Alemnji G.
    J Clin Virol; 2010 Jul; 48(3):173-9. PubMed ID: 20483657
    [Abstract] [Full Text] [Related]

  • 6. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP, Queiroz BB, Stefani MM.
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [Abstract] [Full Text] [Related]

  • 7. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP, Pereira GA, Viegas AA, Schmaltz LE, Stefani MM.
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [Abstract] [Full Text] [Related]

  • 8. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L, Carmona R, Muñoz M, Delgado E, Thomson MM, Contreras G, Pedreira JD, Rodríguez Real R, Vázquez de Parga E, Medrano L, Taboada JA, Nájera R, Spanish Group for Antiretroviral Resistance Studies in Galicia.
    Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
    [Abstract] [Full Text] [Related]

  • 9. Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.
    Derache A, Maiga AI, Traore O, Akonde A, Cisse M, Jarrousse B, Koita V, Diarra B, Carcelain G, Barin F, Pizzocolo C, Pizarro L, Katlama C, Calvez V, Marcelin AG.
    J Antimicrob Chemother; 2008 Sep; 62(3):456-63. PubMed ID: 18556706
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.
    Babic DZ, Zelnikar M, Seme K, Vandamme AM, Snoeck J, Tomazic J, Vidmar L, Karner P, Poljak M.
    Virus Res; 2006 Jun; 118(1-2):156-63. PubMed ID: 16417938
    [Abstract] [Full Text] [Related]

  • 11. HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.
    Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.
    Antivir Ther; 2010 Jun; 15(4):641-50. PubMed ID: 20587857
    [Abstract] [Full Text] [Related]

  • 12. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS, Cardoso LP, Stefani MM.
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [Abstract] [Full Text] [Related]

  • 13. Genotypic resistance profiles in antiretroviral-naive HIV-1 infections before and after initiation of first-line HAART: impact of polymorphism on resistance to therapy.
    Sukasem C, Churdboonchart V, Sukeepaisarncharoen W, Piroj W, Inwisai T, Tiensuwan M, Chantratita W.
    Int J Antimicrob Agents; 2008 Mar; 31(3):277-81. PubMed ID: 18182278
    [Abstract] [Full Text] [Related]

  • 14. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A, Traore O, Koita V, Sylla A, Tubiana R, Simon A, Canestri A, Carcelain G, Katlama C, Calvez V, Cisse M, Marcelin AG.
    Antivir Ther; 2007 Mar; 12(1):123-9. PubMed ID: 17503757
    [Abstract] [Full Text] [Related]

  • 15. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC, Forbici F, Palombi L, Gori C, Coelho E, Svicher V, D'Arrigo R, Emberti-Gialloreti L, Ceffa S, Erba F, Marazzi MC, Silberstein FC, Perno CF.
    J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
    [Abstract] [Full Text] [Related]

  • 16. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ, Kannangai R, Verghese VP, Pulimood SA, Rupali P, Sridharan G, Grant P, Pillay D, Abraham OC.
    Indian J Med Microbiol; 2009 Aug; 27(3):231-6. PubMed ID: 19584504
    [Abstract] [Full Text] [Related]

  • 17. Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.
    Sylla M, Chamberland A, Boileau C, Traoré HA, Ag-Aboubacrine S, Cissé M, Koala S, Drabo J, Diallo I, Niamba P, Tremblay-Sher D, Machouf N, Rashed S, Nickle DC, Nguyen VK, Tremblay CL, ATARAO Group.
    Antivir Ther; 2008 Aug; 13(1):141-8. PubMed ID: 18389909
    [Abstract] [Full Text] [Related]

  • 18. Detection of distinct human immunodeficiency virus type 1 circulating recombinant forms in northeast Brazil.
    Santos LA, Monteiro-Cunha JP, Araujo AF, Brites C, Galvao-Castro B, Alcantara LC.
    J Med Virol; 2011 Dec; 83(12):2066-72. PubMed ID: 22012712
    [Abstract] [Full Text] [Related]

  • 19. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
    Brenner BG, Lowe M, Moisi D, Hardy I, Gagnon S, Charest H, Baril JG, Wainberg MA, Roger M.
    J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
    [Abstract] [Full Text] [Related]

  • 20. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
    Ceccarelli L, Salpini R, Moudourou S, Cento V, Santoro MM, Fokam J, Takou D, Nanfack A, Dori L, Torimiro J, Sarmati L, Andreoni M, Perno CF, Colizzi V, Cappelli G.
    J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.